CD44 and liver cancer: In conclusion, this finding not only provides a new perspective for the preparation of high-performance nanomicelles based on oligomeric HA but also offers strong evidence for the treatment of liver cancer by CD44 targeting and pH-sensitive drug delivery strategies.